Health insurance and AIDS Drug Assistance Program (ADAP) increases retention in care among women living with HIV in the United States.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorKay, Emma Sophia
Alcaide, Maria L
Cohen, Mardge H
Johnson, Mallory O
Moran, Caitlin A
Wilson, Tracey E
KeywordAIDS Drug Assistance Program
Women living with HIV
Women’s Interagency HIV study
retention in care
Journal titleAIDS care
Publication Begin page1044
Publication End page1051
MetadataShow full item record
AbstractOur objective was to examine the association between healthcare payer type and missed HIV care visits among 1,366 US women living with HIV (WLWH) enrolled in the prospective Women's Interagency HIV Study (WIHS). We collected secondary patient-level data (October 1, 2017-September 30, 2018) from WLWH at nine WIHS sites. We used bivariate and multivariable binary logistic regression to examine the relationship between healthcare payer type (cross-classification of patients' ADAP and health insurance enrollment) and missed visits-based retention in care, defined as no-show appointments for which patients did not reschedule. Our sample included all WLWH who self-reported having received HIV care at least once during the two consecutive biannual WIHS visits a year prior to October 1, 2017-September 30, 2018. In the bivariate model, compared to uninsured WLWH without ADAP, WLWH with private insurance + ADAP were more likely to be retained in care, as were WLWH with Medicaid only and private insurance only. In the adjusted model, WLWH with private insurance only were more likely to be retained in care compared to uninsured WLWH without ADAP. Private health insurance and ADAP are associated with increased odds of retention in care among WLWH.
CitationKay ES, Edmonds A, Ludema C, Adimora A, Alcaide ML, Chandran A, Cohen MH, Johnson MO, Kassaye S, Kempf MC, Moran CA, Sosanya O, Wilson TE. Health insurance and AIDS Drug Assistance Program (ADAP) increases retention in care among women living with HIV in the United States. AIDS Care. 2021 Aug;33(8):1044-1051. doi: 10.1080/09540121.2020.1849529. Epub 2020 Nov 25. PMID: 33233937; PMCID: PMC8144231.
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
- Impact of Health Insurance, ADAP, and Income on HIV Viral Suppression Among US Women in the Women's Interagency HIV Study, 2006-2009.
- Authors: Ludema C, Cole SR, Eron JJ Jr, Edmonds A, Holmes GM, Anastos K, Cocohoba J, Cohen M, Cooper HL, Golub ET, Kassaye S, Konkle-Parker D, Metsch L, Milam J, Wilson TE, Adimora AA
- Issue date: 2016 Nov 1
- Health Insurance Type and Control of Hypertension Among US Women Living With and Without HIV Infection in the Women's Interagency HIV Study.
- Authors: Ludema C, Cole SR, Eron JJ Jr, Holmes GM, Anastos K, Cocohoba J, Cohen MH, Cooper HLF, Golub ET, Kassaye S, Konkle-Parker D, Metsch L, Milam J, Wilson TE, Adimora AA
- Issue date: 2017 Jun 1
- Women from afar: an observational study of demographic characteristics and mortality among foreign-born women living with HIV in the Women's Interagency HIV Study (WIHS) in the United States 1994-2016.
- Authors: Adedimeji A, Shi Q, Haddad L, Holman S, Edmonds A, Weber K, Kassaye S, Karim R, Bolivar H, Reid M, Kempf MC, Golub E, Hoover DR, Anastos K
- Issue date: 2020 May
- Dental insurance, dental care utilization, and perceived unmet dental needs in women living with HIV: Results from the Women's Interagency HIV Study.
- Authors: Parish CL, Feaster DJ, Pereyra MR, Alcaide M, Cohen M, Levin S, Gustafson D, Merenstein D, Aouizerat B, Donohue J, Webster-Cyriaque J, Wingood G, Kempf M, Metsch LR
- Issue date: 2019 Dec
- Incident Non-AIDS Comorbidity Burden Among Women With or at Risk for Human Immunodeficiency Virus in the United States.
- Authors: Collins LF, Sheth AN, Mehta CC, Naggie S, Golub ET, Anastos K, French AL, Kassaye S, Taylor TN, Fischl MA, Adimora AA, Kempf MC, Palella FJ, Tien PC, Ofotokun I
- Issue date: 2021 Oct 5